Nifty
Sensex
:
:
23907.25
79117.11
557.35 (2.39%)
1961.32 (2.54%)

Pharmaceuticals & Drugs - Domestic

Rating :
N/A

BSE: 531599 | NSE: FDC

515.30
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  509.90
  •  521.65
  •  507.35
  •  507.30
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  567166
  •  2921.94
  •  658.85
  •  378.20

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 7,959.79
  • 24.94
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 7,914.24
  • N/A
  • 3.45

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 69.66%
  • 2.53%
  • 16.70%
  • FII
  • DII
  • Others
  • 2.62%
  • 5.86%
  • 2.63%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.13
  • 7.65
  • 8.34

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.48
  • 2.94
  • 5.94

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.50
  • 4.85
  • 12.15

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 20.72
  • 21.43
  • 25.46

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.93
  • 2.94
  • 2.87

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.02
  • 14.77
  • 16.11

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
513.85
486.37
5.65%
638.27
536.38
19.00%
462.03
434.80
6.26%
458.17
409.30
11.94%
Expenses
443.69
409.94
8.23%
491.65
414.37
18.65%
405.71
385.85
5.15%
374.38
360.06
3.98%
EBITDA
70.16
76.42
-8.19%
146.62
122.00
20.18%
56.33
48.95
15.08%
83.79
49.23
70.20%
EBIDTM
13.65%
15.71%
22.97%
22.75%
12.19%
11.26%
18.29%
12.03%
Other Income
34.70
27.24
27.39%
28.44
29.42
-3.33%
20.27
7.05
187.52%
24.71
18.41
34.22%
Interest
1.07
1.06
0.94%
1.30
1.05
23.81%
0.95
1.16
-18.10%
0.97
1.20
-19.17%
Depreciation
13.79
9.87
39.72%
11.02
9.63
14.43%
10.44
9.74
7.19%
9.97
9.86
1.12%
PBT
90.00
92.73
-2.94%
162.73
140.74
15.62%
65.21
45.11
44.56%
97.55
56.59
72.38%
Tax
17.96
22.94
-21.71%
43.70
30.93
41.29%
18.93
14.45
31.00%
18.37
15.88
15.68%
PAT
72.04
69.79
3.22%
119.04
109.81
8.41%
46.28
30.66
50.95%
79.17
40.71
94.47%
PATM
14.02%
14.35%
18.65%
20.47%
10.02%
7.05%
17.28%
9.95%
EPS
4.42
4.29
3.03%
7.31
6.62
10.42%
2.84
1.85
53.51%
4.87
2.46
97.97%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
2,072.32
1,942.94
1,783.75
1,527.92
1,333.20
1,344.19
1,090.70
1,075.07
1,013.87
994.32
889.31
Net Sales Growth
11.01%
8.92%
16.74%
14.61%
-0.82%
23.24%
1.45%
6.04%
1.97%
11.81%
 
Cost Of Goods Sold
718.14
656.15
655.79
530.21
414.07
425.72
345.14
352.08
339.05
357.93
272.91
Gross Profit
1,354.18
1,286.79
1,127.96
997.71
919.14
918.46
745.56
722.99
674.81
636.38
616.40
GP Margin
65.35%
66.23%
63.24%
65.30%
68.94%
68.33%
68.36%
67.25%
66.56%
64.00%
69.31%
Total Expenditure
1,715.43
1,604.41
1,534.16
1,274.23
999.15
1,051.25
859.68
848.38
770.40
765.58
690.76
Power & Fuel Cost
-
37.38
34.12
28.91
27.08
27.40
24.61
22.00
21.55
23.14
20.18
% Of Sales
-
1.92%
1.91%
1.89%
2.03%
2.04%
2.26%
2.05%
2.13%
2.33%
2.27%
Employee Cost
-
413.40
390.90
343.33
296.29
277.48
225.57
216.67
191.08
175.76
137.58
% Of Sales
-
21.28%
21.91%
22.47%
22.22%
20.64%
20.68%
20.15%
18.85%
17.68%
15.47%
Manufacturing Exp.
-
171.89
154.81
128.24
77.97
68.80
62.25
58.77
49.40
36.44
97.27
% Of Sales
-
8.85%
8.68%
8.39%
5.85%
5.12%
5.71%
5.47%
4.87%
3.66%
10.94%
General & Admin Exp.
-
107.33
101.01
70.29
55.64
58.06
59.45
61.55
53.35
49.97
41.43
% Of Sales
-
5.52%
5.66%
4.60%
4.17%
4.32%
5.45%
5.73%
5.26%
5.03%
4.66%
Selling & Distn. Exp.
-
187.19
171.01
147.96
87.74
94.70
78.92
75.96
64.36
57.73
64.96
% Of Sales
-
9.63%
9.59%
9.68%
6.58%
7.05%
7.24%
7.07%
6.35%
5.81%
7.30%
Miscellaneous Exp.
-
31.06
26.53
25.28
40.37
99.07
63.73
61.35
51.61
64.61
64.96
% Of Sales
-
1.60%
1.49%
1.65%
3.03%
7.37%
5.84%
5.71%
5.09%
6.50%
6.35%
EBITDA
356.90
338.53
249.59
253.69
334.05
292.94
231.02
226.69
243.47
228.74
198.55
EBITDA Margin
17.22%
17.42%
13.99%
16.60%
25.06%
21.79%
21.18%
21.09%
24.01%
23.00%
22.33%
Other Income
108.12
101.63
51.24
76.09
97.03
68.90
43.47
50.96
50.22
39.00
45.72
Interest
4.29
4.03
4.09
3.09
3.43
3.42
1.44
1.40
1.41
1.40
1.81
Depreciation
45.22
39.92
38.94
37.30
37.81
37.46
33.24
35.14
34.62
33.73
38.81
PBT
415.49
396.22
257.80
289.39
389.83
320.97
239.80
241.11
257.65
232.62
203.65
Tax
98.96
91.16
63.98
73.23
86.53
80.08
66.85
67.12
63.30
63.48
55.51
Tax Rate
23.82%
23.01%
24.82%
25.30%
22.32%
24.95%
28.01%
27.84%
25.14%
27.29%
27.26%
PAT
316.53
305.22
194.04
216.40
301.33
240.89
171.85
173.99
188.47
169.14
148.15
PAT before Minority Interest
316.59
305.06
193.83
216.16
301.18
240.89
171.85
173.99
188.47
169.14
148.15
Minority Interest
0.06
0.16
0.21
0.24
0.15
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
15.27%
15.71%
10.88%
14.16%
22.60%
17.92%
15.76%
16.18%
18.59%
17.01%
16.66%
PAT Growth
26.12%
57.30%
-10.33%
-28.19%
25.09%
40.17%
-1.23%
-7.68%
11.43%
14.17%
 
EPS
19.44
18.75
11.92
13.29
18.51
14.80
10.56
10.69
11.58
10.39
9.10

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
2,097.17
1,982.05
1,956.79
1,734.13
1,547.43
1,445.24
1,276.11
1,270.20
1,082.47
936.38
Share Capital
16.28
16.59
16.88
16.88
17.10
17.52
17.52
17.86
17.86
17.86
Total Reserves
2,080.89
1,965.46
1,939.91
1,717.25
1,530.33
1,427.72
1,258.59
1,252.34
1,064.61
918.52
Non-Current Liabilities
604.16
468.64
391.17
299.63
314.62
229.17
211.41
216.67
19.93
24.06
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.25
0.56
0.65
0.72
0.34
0.49
0.60
0.69
0.79
0.90
Long Term Provisions
574.35
436.75
349.81
281.24
295.78
213.96
194.12
198.60
0.50
0.56
Current Liabilities
615.18
729.56
690.40
621.79
564.62
497.43
480.07
389.40
163.42
187.97
Trade Payables
186.03
178.49
136.94
77.28
117.86
77.61
97.32
75.10
82.59
87.17
Other Current Liabilities
101.50
96.59
86.44
77.36
80.06
61.67
68.78
64.11
50.16
36.61
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.00
Short Term Provisions
327.64
454.48
467.01
467.15
366.69
358.15
313.97
250.19
30.67
63.19
Total Liabilities
3,316.51
3,179.61
3,037.93
2,655.38
2,426.67
2,171.84
1,967.59
1,876.27
1,265.82
1,148.41
Net Block
680.26
698.92
705.06
689.15
673.50
682.19
673.64
678.05
675.16
393.04
Gross Block
987.18
973.27
949.42
897.55
844.97
817.80
776.49
745.84
708.81
629.67
Accumulated Depreciation
306.92
274.35
244.36
208.40
171.47
135.61
102.84
67.79
33.65
236.62
Non Current Assets
1,945.46
1,734.70
1,619.50
1,303.33
1,181.25
1,113.46
976.64
957.93
742.46
646.27
Capital Work in Progress
261.48
198.44
104.82
19.21
23.85
12.38
12.84
6.32
19.92
28.80
Non Current Investment
392.76
348.49
384.73
265.36
162.31
179.11
74.07
54.49
39.43
216.72
Long Term Loans & Adv.
609.51
487.41
424.05
326.65
320.83
239.08
215.28
218.46
7.70
6.37
Other Non Current Assets
1.45
1.45
0.84
2.96
0.75
0.71
0.81
0.60
0.25
1.33
Current Assets
1,367.05
1,443.06
1,418.43
1,352.05
1,245.41
1,058.38
990.94
918.34
523.36
502.13
Current Investments
450.03
457.29
500.77
524.84
502.24
405.93
397.16
436.53
285.41
272.49
Inventories
388.89
328.54
304.70
214.92
209.96
173.79
160.49
137.16
130.91
123.22
Sundry Debtors
117.38
122.65
82.17
110.54
123.74
87.53
81.66
76.06
61.94
61.04
Cash & Bank
26.29
24.94
38.66
31.58
32.32
21.26
29.30
28.47
18.02
14.95
Other Current Assets
384.46
9.94
11.70
19.76
377.15
369.88
322.33
240.12
27.10
30.44
Short Term Loans & Adv.
365.27
499.69
480.43
450.41
350.34
358.56
311.65
230.44
20.36
14.77
Net Current Assets
751.87
713.50
728.03
730.26
680.79
560.94
510.87
528.94
359.94
314.16
Total Assets
3,312.51
3,177.76
3,037.93
2,655.38
2,426.66
2,171.84
1,967.58
1,876.27
1,265.82
1,148.40

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
220.77
154.91
161.65
207.08
250.38
112.43
149.84
154.49
174.30
127.64
PBT
396.22
257.80
289.39
389.85
319.95
237.75
240.63
257.71
232.15
203.65
Adjustment
-51.18
4.32
-26.48
-48.34
22.58
-0.21
0.39
-10.88
2.41
-1.40
Changes in Working Capital
-20.35
-29.91
-21.72
-39.42
-7.77
-51.05
-23.24
-19.23
-4.54
-11.78
Cash after chg. in Working capital
324.69
232.21
241.19
302.09
334.77
186.49
217.78
227.60
230.02
190.48
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-103.92
-77.30
-79.54
-95.01
-84.39
-74.06
-67.94
-70.14
-55.73
-62.84
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-2.97
0.00
0.00
Cash From Investing Activity
-17.08
11.13
-144.57
-77.15
-98.35
-120.33
20.11
-143.55
-73.05
-88.57
Net Fixed Assets
-76.76
-123.01
-136.84
-45.20
-38.52
-40.93
-36.71
-24.24
-81.62
-169.89
Net Investments
-43.73
79.72
-95.30
-125.65
-79.51
-113.70
19.79
-166.18
170.44
-72.39
Others
103.41
54.42
87.57
93.70
19.68
34.30
37.03
46.87
-161.87
153.71
Cash from Financing Activity
-202.16
-179.95
-9.84
-129.35
-142.00
-0.07
-169.43
0.35
-96.98
-47.76
Net Cash Inflow / Outflow
1.53
-13.90
7.25
0.58
10.03
-7.96
0.52
11.29
4.27
-8.69
Opening Cash & Equivalents
23.89
37.73
30.43
29.88
19.92
28.13
27.10
16.25
12.17
23.26
Closing Cash & Equivalent
25.42
23.89
37.73
30.43
29.88
19.92
28.13
27.10
16.25
14.56

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
128.81
119.47
115.92
102.73
90.51
82.86
73.17
71.42
60.87
52.62
ROA
9.39%
6.23%
7.59%
11.85%
10.48%
8.30%
9.05%
12.00%
14.01%
13.34%
ROE
14.96%
9.84%
11.71%
18.36%
16.10%
12.63%
13.67%
16.02%
16.76%
16.64%
ROCE
19.62%
13.27%
15.78%
23.74%
21.63%
17.64%
19.04%
21.51%
23.15%
23.02%
Fixed Asset Turnover
2.04
1.91
1.70
1.57
1.66
1.41
1.42
1.44
1.52
1.65
Receivable days
21.91
20.32
22.35
31.31
27.96
27.55
26.58
23.96
22.06
24.19
Inventory Days
65.48
62.83
60.27
56.79
50.80
54.43
50.15
46.55
45.58
45.45
Payable days
101.39
87.78
73.73
86.01
38.19
40.35
41.32
40.83
44.81
47.89
Cash Conversion Cycle
-14.00
-4.62
8.89
2.09
40.57
41.62
35.41
29.68
22.84
21.74
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest Cover
99.22
64.07
94.67
113.90
94.95
166.95
172.62
179.60
167.11
113.30

News Update:


  • FDC recalling 1,55,232 bottles of Timolol Maleate ophthalmic solution in US market
    18th Nov 2024, 11:00 AM

    The company initiated the Class II recall on October 29, 2024

    Read More
  • FDC recalling bottles of Timolol Maleate Ophthalmic Solution
    27th Aug 2024, 14:42 PM

    FDC is recalling products in the US

    Read More
  • USFDA completes audit at FDC’s Baddi manufacturing facility
    23rd Aug 2024, 16:30 PM

    USFDA has completed audit with No observations

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.